The relevance of the TF SP1 in regulating miR-29b expression has been also proven in AML bearing KIT mutations, where SP1 participates in an epigenetic complex formed by NF-kB/HDAC which represses miR-29b transcription. This evidence concerns the gene SP1 and acute myeloid leukemia.